RecruitingNCT05418218

International Headache Registry Study

International Headache and Vertigo Registration Study


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

200,000 participants

Start Date

Jul 12, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.


Eligibility

Min Age: 4 YearsMax Age: 99 Years

Inclusion Criteria4

  • The following are requirements for entry into the study:
  • Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
  • Male or female participants ages 4 to 99 years, inclusive, at Visit 1.
  • Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches, and patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).

Exclusion Criteria2

  • Patients who were unable to complete scales such as headache diary.
  • Patients denied or unable to be admitted for long-term follow-up.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Kaiming Liu

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05418218


Related Trials